Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.
2.

Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.

Chakraborty S, Mohiyuddin SM, Gopinath KS, Kumar A.

BMC Cancer. 2008 Jun 6;8:163. doi: 10.1186/1471-2407-8-163.

3.

Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma.

Mikami T, Hada T, Chosa N, Ishisaki A, Mizuki H, Takeda Y.

J Oral Pathol Med. 2013 Feb;42(2):133-9. doi: 10.1111/j.1600-0714.2012.01182.x. Epub 2012 Jun 5.

PMID:
22672247
4.

Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.

Vidovic K, Svensson E, Nilsson B, Thuresson B, Olofsson T, Lennartsson A, Gullberg U.

Leukemia. 2010 May;24(5):992-1000. doi: 10.1038/leu.2010.33. Epub 2010 Mar 18.

PMID:
20237505
5.

Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics.

Rather MI, Nagashri MN, Swamy SS, Gopinath KS, Kumar A.

J Biol Chem. 2013 Jan 4;288(1):608-18. doi: 10.1074/jbc.M112.425736. Epub 2012 Nov 19.

6.

Transcriptional repression of DLEC1 associates with the depth of tumor invasion in oral squamous cell carcinoma.

Chan WH, Chang KP, Yang SW, Yao TC, Ko TY, Lee YS, Tsai CL, Tsai CN.

Oral Oncol. 2010 Dec;46(12):874-9. doi: 10.1016/j.oraloncology.2010.09.007. Epub 2010 Oct 16.

PMID:
20952247
7.

Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.

Baba S, Hara A, Kato K, Long NK, Hatano Y, Kimura M, Okano Y, Yamada Y, Shibata T.

Oncol Rep. 2009 Nov;22(5):1173-9.

PMID:
19787237
8.

The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53.

Stanhope-Baker P, Kessler PM, Li W, Agarwal ML, Williams BR.

J Biol Chem. 2004 Aug 6;279(32):33575-85. Epub 2004 May 21.

9.

Characterization of a new CDC73 missense mutation that impairs Parafibromin expression and nucleolar localization.

Masi G, Iacobone M, Sinigaglia A, Mantelli B, Pennelli G, Castagliuolo I, Palù G, Barzon L.

PLoS One. 2014 May 19;9(5):e97994. doi: 10.1371/journal.pone.0097994. eCollection 2014.

11.

The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells.

Bourkoula K, Englert C, Giaisi M, Köhler R, Krammer PH, Li-Weber M.

Int J Cancer. 2014 Jan 15;134(2):291-300. doi: 10.1002/ijc.28379. Epub 2013 Aug 9.

12.

WT1 promotes invasion of NSCLC via suppression of CDH1.

Wu C, Zhu W, Qian J, He S, Wu C, Chen Y, Shu Y.

J Thorac Oncol. 2013 Sep;8(9):1163-9. doi: 10.1097/JTO.0b013e31829f6a5f.

13.

CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma.

Zhang H, Nan X, Li X, Chen Y, Zhang J, Sun L, Han W, Li T.

Biochem Biophys Res Commun. 2014 May 2;447(2):304-10. doi: 10.1016/j.bbrc.2014.03.158. Epub 2014 Apr 8.

PMID:
24721428
14.

Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.

Hewitt SM, Hamada S, McDonnell TJ, Rauscher FJ 3rd, Saunders GF.

Cancer Res. 1995 Nov 15;55(22):5386-9.

15.

Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.

Han Y, Yang L, Suarez-Saiz F, San-Marina S, Cui J, Minden MD.

Mol Cancer Res. 2008 Aug;6(8):1347-55. doi: 10.1158/1541-7786.MCR-07-2179.

16.

Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.

Su L, Wang Y, Xiao M, Lin Y, Yu L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):484-91. doi: 10.1016/j.tripleo.2010.04.009.

PMID:
20868995
17.

Overexpression of the Wilms' tumor gene WT1 in head and neck squamous cell carcinoma.

Oji Y, Inohara H, Nakazawa M, Nakano Y, Akahani S, Nakatsuka S, Koga S, Ikeba A, Abeno S, Honjo Y, Yamamoto Y, Iwai S, Yoshida K, Oka Y, Ogawa H, Yoshida J, Aozasa K, Kubo T, Sugiyama H.

Cancer Sci. 2003 Jun;94(6):523-9.

18.

Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms.

Li Y, Wang J, Li X, Jia Y, Huai L, He K, Yu P, Wang M, Xing H, Rao Q, Tian Z, Tang K, Wang J, Mi Y.

Oncol Rep. 2014 Dec;32(6):2680-6. doi: 10.3892/or.2014.3529. Epub 2014 Oct 6.

PMID:
25310451
19.

Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma.

Lee CH, Wong TS, Chan JY, Lu SC, Lin P, Cheng AJ, Chen YJ, Chang JS, Hsiao SH, Leu YW, Li CI, Hsiao JR, Chang JY.

J Pathol. 2013 Jul;230(3):298-309. doi: 10.1002/path.4173. Epub 2013 Mar 21.

PMID:
23362108
20.

NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.

Furuta H, Kondo Y, Nakahata S, Hamasaki M, Sakoda S, Morishita K.

Biochem Biophys Res Commun. 2010 Jan 22;391(4):1785-91. doi: 10.1016/j.bbrc.2009.12.156. Epub 2010 Jan 5.

PMID:
20045673

Supplemental Content

Support Center